MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 59 filers reported holding MIRAGEN THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $139,000 | -89.2% | 290,000 | -83.6% | 0.02% | -88.9% |
| Q3 2019 | $1,291,000 | -64.3% | 1,766,038 | 0.0% | 0.14% | -56.2% |
| Q2 2019 | $3,620,000 | -26.5% | 1,766,038 | 0.0% | 0.33% | -26.4% |
| Q1 2019 | $4,927,000 | -4.2% | 1,766,038 | +4.1% | 0.45% | +43.3% |
| Q4 2018 | $5,142,000 | +60.4% | 1,697,038 | +239.4% | 0.31% | +43.8% |
| Q2 2018 | $3,205,000 | -8.6% | 500,000 | 0.0% | 0.22% | -30.0% |
| Q1 2018 | $3,505,000 | – | 500,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 92,200 | $646,000 | 0.88% |
| 683 Capital Management, LLC | 500,000 | $3,505,000 | 0.31% |
| BIEGEL & WALLER LLC | 66,508 | $466,000 | 0.30% |
| Monashee Investment Management LLC | 94,000 | $659,000 | 0.18% |
| Aveo Capital Partners, LLC | 16,732 | $117,000 | 0.05% |
| Artal Group S.A. | 500,000 | $3,505,000 | 0.04% |
| Radnor Capital Management, LLC | 10,000 | $70,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 12,672 | $89,000 | 0.01% |
| Trexquant Investment LP | 15,757 | $110,000 | 0.01% |
| FMR LLC | 4,332,888 | $30,374,000 | 0.00% |